Annular crystalline keratopathy in association with immunoglobulin therapy for pyoderma gangrenosum

Cornea

Volumn 22, Issue 1, 2003, Pages 82-85

  Budde, Maike ^a   Gusek Schneider, Gabriele C ^a   Mayer, Ursula ^a   Seitz, Berthold ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Department of Ophthalmology ^*  (Germany)

Author keywords

Annular keratopathy; Crystalline keratopathy; Hyperglobulinemia; Pyoderma gangrenosum

Indexed keywords

AMIODARONE; CHLOROQUINE; ERGOTAMINE; GOLD; IMMUNOGLOBULIN; INDOMETACIN; QUININE DERIVATIVE; SILVER; UNCLASSIFIED DRUG; VIQUIDIL; VITAMIN D;

ARTICLE; BIOMICROSCOPY; CASE REPORT; HUMAN; IMMUNOTHERAPY; KERATOPATHY; MALE; MEDICAL LITERATURE; PHOTOPHOBIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SLIT LAMP; SYMPTOM; VISUAL ACUITY;

CHILD; CORNEAL DISEASES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PYODERMA GANGRENOSUM; VISION DISORDERS; VISUAL ACUITY;

EID: 0037224109     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200301000-00021     Document Type: Article

References (35)

1. Wilson DM, John GR, Callen, JP. Peripheral ulcerative keratitis - An extracutaneous neutrophilic disorder: Report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 1999;40:331-4.
2. Novartis Pharma GmbH Deutschland. Sandoglobulin (Dose Information). Novartis Pharma GmbH Deutschland, Nürnberg, 2001.
3. von den Driesch P. Pyoderma gangrenosum: A report of 44 cases with follow up. Br J Dermatol 1997;137:1000-5.
4. Bishop P, Tullo A. Pyoderma gangrenosum and necrotizing sclerokeratitis. Cornea 1998;17:346-7.
5. Bouchard CS, Meyer MA, McDonnell JF. Bilateral peripheral ulcerative keratitis associated with pyoderma gangrenosum. Cornea 1997;16:480-2.
6. Brown BA, Parker CT, Bower KS. Effective steroid-sparing treatment of peripheral ulcerative keratitis and pyoderma gangrenosum. Cornea 2001;20:117-8.
7. Chen TC, Goldstein DA, Tessler HH, et al. Scleritis associated with acute febrile neutrophilic dermatosis (Sweet's syndrome). A propos of a case. Rev Med Interne 1997;18:734-5.
8. Cohen PR. Sweet's syndrome presenting as conjunctivitis. Arch Ophthalmol 1993;111:587-8.
9. Fourman S. Inflammatory glaucoma associated with Sweet's syndrome. Am J Ophthalmol 1988;105:691-2.
10. Gunawardena DA, Gunawardena KA, Ratnayaka RMRS, et al. The clinical spectrum of Sweet's syndrome (acute febrile neutrophilic dermatosis). A report of eighteen cases. Br J Dermatol 1975;92:363-3.
11. Medenblick-Frysch S, von den Driesch P, Jonas JB, et al. Ocular complications in Sweet's syndrome. Am J Ophthalmol 1992;114:230-1.
12. Nicolaides A, Packles MR, Schutzer PJ, et al. Iritis associated with Sweet's syndrome. Clin Exp Dermatol 2000;25:352-3.
13. Davies R. Limbal nodules in Sweet's syndrome. Aust N Z J Ophthalmol 1992;20:263-5.
14. Robin JB, Schanzlin DJ, Verity SM, et al. Peripheral corneal disorders. Surv Ophthalmol 1986;31:1-36.
15. Rohrbach JM, Nölle B, Amm M, et al. Ringförmige hornhauttrübungen. [Circular corneal opacities]. Ophthalmologe 2001;98:674-96.
16. Kaufman HE, Barron BA, McDonald MD, eds. The Cornea, 2nd Ed. Boston: Butterworth-Heinemann, 1998.
17. Meesmann A. Über eine eigenartige hornhautdegeneration. Ablagerung des Bence-Jones-Eiweißkörperchens in der hornhaut. Ber Dtsch Ophthalmol Ges 1934;50:311-5.
18. Klintworth GK. Proteins in ocular disease. In: Garner A, Klintworth GK, eds. Pathobiology of Ocular Disease: A Dynamic Approach, 2nd Ed. New York: Dekker, 1995:985-7.
19. Ormerod LD, Collin HB, Dohlman CH, et al. Paraproteinemic crystalline keratopathy. Ophthalmology 1988;95:202-2.
20. Sekundo W, Seifert P. Monoclonal corneal gammopathy: Topographic considerations. Ger J Ophthabnol 1996;5:262-7.
21. Chong EM, Campbell RJ, Bourne WM. Vortex keratopathy in a patient with multiple myeloma. Cornea 1997;16:592-4.
22. Hoisen H, Ringvold A, Kildahl-Andersen O. Corneal crystalline deposits in multiple myeloma. A case report. Acta Ophthalmol (Copenh) 1983;61:493-500.
23. Gabel J, Seitz B, Hantsch A, et al. Kristalline keratopathie als erstsymptom eines plasmozytoms [Crystalline keratopathy as a presenting sign of multiple myeloma]. Kiln Monatsbl Augenheilkd 1999;214:412-4.
24. Stirling JW, Henderson DW, Rozenbilds MA, et al. Crystalloidal paraprotein deposits in the cornea: An ultrastructural study of two new cases with tubular crystalloids that contain IgG kappa light chains and IgG gamma heavy chains. Ultrastruct Pathol 1997;21:337-44.
25. Allansmith MR, McClellan BH. Immunoglobulins in the human cornea. Am J Ophthalmol 1975;80:123-32.
26. Allansmith MR, Whitney CR, McClellan BH, et al. Immunoglobulins in the human eye. Location, type, and amount. Arch Ophthalmol 1973;89:36-45.
27. Eiferman RA, Rodrigues MM. Unusual superficial stromal corneal deposits in IgG kappa monoclonal gammopathy. Arch Ophthalmol 1980;98:78-81.
28. Garner A, Kirkness CM. Corneal gammopathy. Cornea 1988;7:44-9.
29. Kato T, Nakayasu K, Omata Y, et al. Corneal deposits as an alerting sign of monoclonal gammopathy: A case report. Cornea 1999;18:734-8.
30. Steuhl K-P, Knorr M, Rohrbach JM, et al. Paraproteinemic corneal deposits in plasma cell myeloma. Am J Ophthalmol 1991;111:312-8.
31. Beebe WE, Webster RG Jr, Spencer WB. Atypical corneal manifestations of multiple myeloma. Cornea 1989;8:274-80.
32. Allansmith M, de Ramus A, Maurice D. The dynamics of IgG in the cornea. Invest Ophthalmol Vis Sci 1979;18:947-55.
33. Osusky R, Morell A, Imbach P, et al. Diffusion of immunoglobulins into rabbit cornea after subconjunctival injection: Experimental demonstration and mathematical model. Graefes Arch Clin Exp Ophthalmol 1993;231:122-8.
34. Maurice DM, Watson PG. The distribution and movement of serum albumin in the cornea. Exp Eye Res 1965;4:355-63.
35. Melles GR, de Sera JP, Eggink CA, et al. Bilateral, anterior stromal ring opacity of the cornea. Br J Ophthalmol 1998;82:522-5.